Welcome to LookChem.com Sign In|Join Free

CAS

  • or

168465-69-8

Post Buying Request

168465-69-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

168465-69-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 168465-69-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,4,6 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 168465-69:
(8*1)+(7*6)+(6*8)+(5*4)+(4*6)+(3*5)+(2*6)+(1*9)=178
178 % 10 = 8
So 168465-69-8 is a valid CAS Registry Number.

168465-69-8Relevant articles and documents

A Green approach towards the synthesis of chiral alcohols using functionalized alginate immobilized Saccharomyces cerevisiae cells

Muthineni, Narmada,Arnipally, Manikanta Swamy,Bojja, Sridhar,Meshram, Harshadas Mitaram,Srivastava, Ajay Kumar,Adari, Bhaskar Rao

, p. 233 - 237 (2016/12/09)

The stereochemistry of the drug molecule is gaining greater therapeutic importance and thus much attention was drawn in synthesis of chiral compounds by the pharmaceutical industry. In this study Saccharomyces cerevisiae cells immobilized on functionalize

[3H]-(R)-NPTS, a radioligand for the type 1 glycine transporter.

Lowe 3rd., John A,Drozda, Susan E,Fisher, Katherine,Strick, Christine,Lebel, Lorraine,Schmidt, Christopher,Hiller, Donna,Zandi, Kathleen S

, p. 1291 - 1292 (2007/10/03)

The synthesis of NPTS, 6, a potent inhibitor of the type 1 glycine transporter (GlyT1) is described, as well as preparation of 6 in optically active and tritiated form for use as a radioligand for affinity displacement assay of GlyT1.

Novel use of phenylheteroakylamine derivatives

-

, (2008/06/13)

There is disclosed the use of a compound of formula (I) wherein R1, R2, X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts, enantiomers or racemates thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of nitric oxide synthase activity is beneficial. Certain novel compounds of formula (Ia) and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof are disclosed; together with processes for their preparation, compositions containing them and their use in therapy. The compounds of formulae (I) and (Ia) are inhibitors of the enzyme nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 168465-69-8